Cargando…

Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery

BACKGROUND: People living with HIV (PLWH) have a higher risk for cancer compared to the general population. The prevalence of renal cell carcinoma (RCC) in PLWH has gradually increased in recent years, but relevant data on outcomes after surgery are scarce. We thus evaluated long-term outcomes after...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Wu, Menghua, Zheng, Xin, Zhang, Yu, Zhao, Jimao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270790/
https://www.ncbi.nlm.nih.gov/pubmed/35804319
http://dx.doi.org/10.1186/s12879-022-07592-z
_version_ 1784744542823514112
author Chen, Liang
Wu, Menghua
Zheng, Xin
Zhang, Yu
Zhao, Jimao
author_facet Chen, Liang
Wu, Menghua
Zheng, Xin
Zhang, Yu
Zhao, Jimao
author_sort Chen, Liang
collection PubMed
description BACKGROUND: People living with HIV (PLWH) have a higher risk for cancer compared to the general population. The prevalence of renal cell carcinoma (RCC) in PLWH has gradually increased in recent years, but relevant data on outcomes after surgery are scarce. We thus evaluated long-term outcomes after surgery in RCC patients with and without HIV. METHODS: This retrospective study included 67 patients with RCC, both HIV positive or negative, who underwent surgical treatment in our hospital between January 2012 and January 2021. Demographic details, clinical data, and cancer status were collected. We set the day of surgery as the baseline. The co-primary end points in this time-to-event analysis were overall survival and progression-free survival. We used a multivariate Cox model to compare the prognosis of PLWH and HIV-negative patients and present Kaplan–Meier curves for the co-primary end points. RESULTS: Of 261 consecutive patients, 18 patients who forwent treatment before surgery, 133 cases with incomplete data, 16 patients classified as clinical stage IV, 11 PLWH patients did not received antiretroviral therapy and 16 patients with metastasis were excluded from the main analysis. Of the remaining 67 patients, 33 individuals had HIV and the other 34 did not. The median overall survival was 74.9 months (95% confidence interval [CI] = 64.6 to 85.2) in PLWH and 96.4 months (95% CI = 90.0 to 102.9) in the HIV-negative group. Progression-free survival was 66.4 months (95% CI = 53.5 to 79.3) and 90.6 months (95% CI = 81.1 to 100.1), respectively. RCC patients with HIV who underwent surgery had a shorter survival time (hazard ratio [HR] = 2.8, 95% CI = 1.1 to 7.0, p = 0.016) and an increased incidence of tumor progression (HR = 2.7, 95% CI = 1.1 to 6.8, p = 0.028). Univariate and multivariate Cox regression analyses showed that a lower ratio of CD4(+) T cells to CD8(+) T cells (adjusted odds ratio = 0.092, 95% CI = 0.01 to 0.70, p = 0.022) was associated with worse survival among PLWH. CONCLUSION: In this retrospective analysis of RCC patients who underwent surgery, PLWH had worse overall survival and shorter progression-free survival compared to HIV-negative cases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07592-z.
format Online
Article
Text
id pubmed-9270790
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92707902022-07-10 Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery Chen, Liang Wu, Menghua Zheng, Xin Zhang, Yu Zhao, Jimao BMC Infect Dis Research BACKGROUND: People living with HIV (PLWH) have a higher risk for cancer compared to the general population. The prevalence of renal cell carcinoma (RCC) in PLWH has gradually increased in recent years, but relevant data on outcomes after surgery are scarce. We thus evaluated long-term outcomes after surgery in RCC patients with and without HIV. METHODS: This retrospective study included 67 patients with RCC, both HIV positive or negative, who underwent surgical treatment in our hospital between January 2012 and January 2021. Demographic details, clinical data, and cancer status were collected. We set the day of surgery as the baseline. The co-primary end points in this time-to-event analysis were overall survival and progression-free survival. We used a multivariate Cox model to compare the prognosis of PLWH and HIV-negative patients and present Kaplan–Meier curves for the co-primary end points. RESULTS: Of 261 consecutive patients, 18 patients who forwent treatment before surgery, 133 cases with incomplete data, 16 patients classified as clinical stage IV, 11 PLWH patients did not received antiretroviral therapy and 16 patients with metastasis were excluded from the main analysis. Of the remaining 67 patients, 33 individuals had HIV and the other 34 did not. The median overall survival was 74.9 months (95% confidence interval [CI] = 64.6 to 85.2) in PLWH and 96.4 months (95% CI = 90.0 to 102.9) in the HIV-negative group. Progression-free survival was 66.4 months (95% CI = 53.5 to 79.3) and 90.6 months (95% CI = 81.1 to 100.1), respectively. RCC patients with HIV who underwent surgery had a shorter survival time (hazard ratio [HR] = 2.8, 95% CI = 1.1 to 7.0, p = 0.016) and an increased incidence of tumor progression (HR = 2.7, 95% CI = 1.1 to 6.8, p = 0.028). Univariate and multivariate Cox regression analyses showed that a lower ratio of CD4(+) T cells to CD8(+) T cells (adjusted odds ratio = 0.092, 95% CI = 0.01 to 0.70, p = 0.022) was associated with worse survival among PLWH. CONCLUSION: In this retrospective analysis of RCC patients who underwent surgery, PLWH had worse overall survival and shorter progression-free survival compared to HIV-negative cases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07592-z. BioMed Central 2022-07-09 /pmc/articles/PMC9270790/ /pubmed/35804319 http://dx.doi.org/10.1186/s12879-022-07592-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Liang
Wu, Menghua
Zheng, Xin
Zhang, Yu
Zhao, Jimao
Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery
title Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery
title_full Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery
title_fullStr Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery
title_full_unstemmed Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery
title_short Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery
title_sort long-term outcome of renal cell carcinoma in patients with hiv who undergo surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270790/
https://www.ncbi.nlm.nih.gov/pubmed/35804319
http://dx.doi.org/10.1186/s12879-022-07592-z
work_keys_str_mv AT chenliang longtermoutcomeofrenalcellcarcinomainpatientswithhivwhoundergosurgery
AT wumenghua longtermoutcomeofrenalcellcarcinomainpatientswithhivwhoundergosurgery
AT zhengxin longtermoutcomeofrenalcellcarcinomainpatientswithhivwhoundergosurgery
AT zhangyu longtermoutcomeofrenalcellcarcinomainpatientswithhivwhoundergosurgery
AT zhaojimao longtermoutcomeofrenalcellcarcinomainpatientswithhivwhoundergosurgery